⌘K

Login Start Free

Home/Filings/4/0001493152-23-009348

4//SEC Filing

Ruskin Barbara 4

Accession 0001493152-23-009348

CIK 0001708331other

View on SEC.gov Company Profile

Filed

Mar 27, 8:00 PM ET

Accepted

Mar 28, 8:05 PM ET

Size

5.2 KB

Accession

0001493152-23-009348

Insider Transaction Report

Form 4

Period: 2023-03-24

Virpax Pharmaceuticals, Inc.VRPX

Director

Transactions

Award
Stock Option (right to buy)
2023-03-24+25,000→ 25,000 total
Exercise: $0.84From: 2024-03-24Exp: 2033-03-24→ Common Stock (25,000 underlying)

Documents

1 file

4
ownership.xmlPrimary

Issuer

Virpax Pharmaceuticals, Inc.

CIK 0001708331

Entity typeother

Related Parties

1

filerCIK 0001969041

Filing Metadata

Form type: 4
Filed: Mar 27, 8:00 PM ET
Accepted: Mar 28, 8:05 PM ET
Size: 5.2 KB

View on SEC.gov